Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia
Multicenter, Open Label Clinical Trial to Evaluate the Effect and Tolerability of Minoxidil 2% Solution and Botanical Hair Solution Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia (Ludwig I and II)
1 other identifier
interventional
61
1 country
1
Brief Summary
The purpose of this study is to characterize the effect of Minoxidil 2% Solution and Botanical Hair Solution Regimen in women with thinning hair and female pattern hair loss/androgenic alopecia (Ludwig I and II).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2015
CompletedFirst Submitted
Initial submission to the registry
May 29, 2015
CompletedFirst Posted
Study publicly available on registry
June 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 19, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2015
CompletedResults Posted
Study results publicly available
August 1, 2023
CompletedAugust 1, 2023
July 1, 2023
4 months
May 29, 2015
March 20, 2023
July 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change From Baseline in Investigator's Rating of Global Photographs at Week 12
The Investigator or a trained grader rated each participant's standardized global photographs for improvement from baseline for parameters like hair thinning, hair growth, impression of scalp hair coverage and overall perception of treatment benefit using a 1-to-7-point Likert scale. The score on the scale ranged from 1 (minimum) to 7 (maximum), that is, (1) Entirely Disagree; (2) Mostly Disagree; (3) Somewhat Disagree; (4) Neither Agree nor Disagree; (5) Somewhat Agree; (6) Mostly Agree; (7) Entirely Agree.
At Week 12
Secondary Outcomes (4)
Change From Baseline in Participant Rating at Week 12
At Week 12
Mean Change From Baseline in Shed Hair Count
At Week 12
Number of Participants in Each Response Category Based on Subject Satisfaction Questionnaire
At Week 4, 6 and 12
Number of Participants With Adverse Events (AEs)
From start of study drug administration up to Week 12
Study Arms (1)
Treatment
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Female patients age 18 to 60 years at the time of enrollment.
- Women who have self-perceived thinning hair.
- Women who have presentation of female pattern hair loss/androgenic alopecia (Ludwig I and II).
You may not qualify if:
- History of allergic reactions or severe intolerance to minoxidil and Botanical Hair Solution product ingredients.
- Plan to use any other concomitant therapy to treat hair loss, regrowth or volume during the study.
- Subjects taking or planning to take topical or systemic prescription or OTC medications for treating hair loss and/or hair volume.
- \. Any significant history of concurrent medical disease, which in the judgment of the Investigator, would make the subject inappropriate for entry to this study including history of skin disease that may confound study results.
- \. Subjects who have recently (within the last 6 months) started the use of hormones for birth control or hormone replacement therapy (HRT). Women currently using hormones for birth control or HRT must have been on a stable dose (6 months or longer) in order to be eligible for the study.
- \. Pregnant or breast-feeding females or women planning to become pregnant during the course of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Galderma R&Dlead
Study Sites (1)
Stephens & Associates
Richardson, Texas, 75081, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clinical Operations
- Organization
- Galderma
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 29, 2015
First Posted
June 2, 2015
Study Start
May 27, 2015
Primary Completion
September 19, 2015
Study Completion
September 19, 2015
Last Updated
August 1, 2023
Results First Posted
August 1, 2023
Record last verified: 2023-07